Spots Global Cancer Trial Database for Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)
Official Title:
Study ID: NCT00034957
Interventions
Study Description
Brief Summary: The primary goal of the study is to evaluate an investigational drug's effectiveness as a treatment for Non small-cell lung cancer (NSCLC)
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Center, Berkeley, California, United States
Research Center, Greenbrae, California, United States
Research Center, Los Angeles, California, United States
Research Center, Rancho Mirage, California, United States
Research Center, Chicago, Illinois, United States
Research Center, Louisville, Kentucky, United States
Research Center, West Boylston, Massachusetts, United States
Research Center, Ann Arbor, Michigan, United States
Research Center, Lebanon, New Hampshire, United States
Research Center, Nashville, Tennessee, United States
Research Center, Arlington, Texas, United States
Research Center, Dallas, Texas, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
